For businesses preparing to undertake an public offering, rigorous adherence to Good Manufacturing Practices (cGMP) is absolutely critical. Regulatory bodies, such as the FDA, frequently scrutinize company's operations processes to ensure product quality and patient safety. Lack to prove robust adherence to GMP can result in delays in the listing s